The Recall Desk
SevereFDA (Drugs)·D-0850-2026·Announced 2026-09-16

Baxter Recalls Dextrose Injection Bags Due to Stainless Steel Particulate Matter

Baxter Healthcare is recalling 606 bags of Dextrose Injection, USP, 70% due to the presence of stainless steel particles in the solution.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.

Plain-English summary

Baxter Healthcare Corporation is recalling 606 bags of Dextrose Injection, USP, 70%, 2000 mL bags (NDC 00338-0719-06). The recall is due to the presence of particulate matter, specifically identified as stainless steel particles, in the solution.

The affected product is Lot #Y495066 with an expiration date of July 31, 2027. The product was distributed nationwide in the United States.

Healthcare providers and patients should stop using the affected product and contact Baxter Healthcare Corporation for further instructions.

The recalled product

Product
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
Affected units
606

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot #: Y495066
  • Exp. Date July 31
  • 2027

Distribution

Distributed nationwide across the United States.